Bifogade filer
Kurs & Likviditet
Beskrivning
Land | Sverige |
---|---|
Lista | Spotlight |
Sektor | Hälsovård |
Industri | Medicinteknik |
2021-09-29 10:30:00
(Stockholm, Sweden, 29 September, 2021) Inhalation Sciences AB (ISAB) announces today it has commissioned Redeye to produce regular, in-depth stock analyses of the company. The strategic goal is to increase ISAB's market profile and visibility, enabling investors and stakeholders to develop a better understanding of the business and its performance and prospects.
Redeye specializes in providing analysis and insights into companies within the Nordic region's fast-growing and innovative Life Science and Technology sector. Redeye's first report on ISAB has now been published and is available on ISAB's website, https://www.inhalation.se/investors/bolagsanalys/, and on Redeye's website, www.redeye.se/company/inhalationsciences.